Cargando…
Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Despite notable therapeutic advances in the last decades, 30%–40% of affected patients develop relapsed or refractory disease that frequently precludes an infamous outcome. With the advent of new therapeutic optio...
Autores principales: | Mosquera Orgueira, Adrián, Díaz Arías, Jose Ángel, Cid López, Miguel, Peleteiro Raíndo, Andrés, López García, Alberto, Abal García, Rosanna, González Pérez, Marta Sonia, Antelo Rodríguez, Beatriz, Aliste Santos, Carlos, Pérez Encinas, Manuel Mateo, Fraga Rodríguez, Máximo Francisco, Bello López, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984321/ https://www.ncbi.nlm.nih.gov/pubmed/35392483 http://dx.doi.org/10.1097/HS9.0000000000000706 |
Ejemplares similares
-
Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022) -
Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2020) -
Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021) -
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021) -
A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2023)